title: [Different influence of Her-2 expression on the prognosis in node-positive and node-negative breast cancer].
authors.affiliation: Breast Center, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing 100142, China.
authors.forename: Yan
authors.initials: Y
authors.lastname: Wang
authors.forename: Lu
authors.initials: L
authors.lastname: Yao
authors.forename: Yi-qang
authors.initials: YQ
authors.lastname: Liu
authors.forename: Ye
authors.initials: Y
authors.lastname: Xu
authors.forename: Yang-tao
authors.initials: YT
authors.lastname: Ou
authors.forename: Jin-feng
authors.initials: JF
authors.lastname: Li
authors.forename: Tian-feng
authors.initials: TF
authors.lastname: Wang
authors.forename: Zhao-qing
authors.initials: ZQ
authors.lastname: Fan
authors.forename: Tie
authors.initials: T
authors.lastname: Fan
authors.forename: Ben-yao
authors.initials: BY
authors.lastname: Lin
authors.forename: Yun-tao
authors.initials: YT
authors.lastname: Xie
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000378:metabolism* / Q000473:pathology*; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology*; D008207:Lymphatic Metastasis; D008875:Middle Aged; D009367:Neoplasm Staging; D016016:Proportional Hazards Models; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*; D011980:Receptors, Progesterone / Q000378:metabolism; D015996:Survival Rate
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases; D011980:Receptors, Progesterone; C508053:ERBB2 protein, human